Harmony Biosciences Inc. (HRMY)

32.21

-1.64 (-4.84%)

At close: Mar 03, 2025, 3:59 PM

32.18

-0.09%

After-hours: Mar 03, 2025, 04:00 PM EST

Harmony Biosciences Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	145.49M	128.85M	181.47M	34.6M	-36.94M	-151.98M	-39.9M
Depreciation & Amortization	24.11M	24.36M	23.39M	18.84M	10.24M	3.21M	184K
Stock-Based Compensation	42.6M	31.7M	26.17M	15.66M	4.69M	9.91M	1.08M
Other Working Capital	n/a	46.55M	12.87M	15.46M	12.83M	8.74M	446K
Other Non-Cash Items	36.91M	12.85M	3.49M	2.68M	4.91M	55.13M	2.06M
Deferred Income Tax	-29.3M	-13.42M	-85.94M	26.15M	25.75M	n/a	n/a
Change in Working Capital	n/a	35.03M	-4.11M	631K	-11.63M	8.29M	-164K
Operating Cash Flow	219.82M	219.39M	144.47M	98.56M	-2.98M	-75.44M	-38.8M
Capital Expenditures	-1.15M	-312K	-40.17M	-100.3M	-2M	-127.15M	-1.34M
Acquisitions	-33.07M	-36.97M	141.83M	-100M	-2M	-52M	n/a
Purchase of Investments	-105.29M	-127.47M	-110.73M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	98.53M	118.31M	9.07M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-26.5M	n/a	-141.83M	100M	2M	52M	n/a
Investing Cash Flow	-67.48M	-46.44M	-141.83M	-100.3M	-2M	-127.15M	-1.34M
Debt Repayment	-15M	-1.25M	-2M	-500K	79.42M	100M	n/a
Common Stock Repurchased	n/a	-100M	n/a	n/a	-167K	-1.13M	-3.2M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4M	-4.3M	8.84M	-22.08M	-17.71M	93.77M	24.82M
Financial Cash Flow	-11M	-105.55M	6.84M	7.42M	209.16M	143.77M	21.61M
Net Cash Flow	141.34M	67.4M	9.47M	5.68M	204.17M	-58.82M	-18.53M
Free Cash Flow	218.67M	219.07M	104.29M	-1.74M	-4.99M	-202.59M	-40.14M